With Covid 19, Korea is emerging as a suitable city for clinical trials. Seoul, the capital of Korea, has been the city that conducted the most clinical trials in the world. The market for clinical trials will continue to increase in the number of new drug candidates poured out by companies using AI, we are expecting the number of new drug candidates will increase 40 times by 2024.
As the need for clinical trials increased, we developed the “MediC” platform. We collected global clinical trials information from all publically available databases. Using deep learning technologies on biomedical literature and AI to optimize our clinical trials database, we guide the drug development process spending less time and expenses to provide treatments faster.
We are preparing 3 patent cooperation treaty (PCT) applications and 3 Korean technology patents.